For example, in a 2012 article published in Lancet Oncology, the WHI investigators were already backtracking on their claims about estrogen and breast cancer. Women on estrogen alone, they reported, were less likely to die of breast cancer—indeed, less likely to die from all causes after a breast cancer diagnosis—than women assigned to placebo.